See the DrugPatentWatch profile for lipitor

Based on the information available, there have been studies conducted to evaluate the impact of Lipitor (atorvastatin) on liver function. However, it is essential to note that the most recent studies seem to focus on the overall safety and efficacy of atorvastatin, including its effects on liver function, rather than exclusively investigating new impacts on the liver.

A study published in 2019 in the Journal of Clinical Lipidology [1] analyzed the safety and efficacy of atorvastatin in a real-world setting. The study found that atorvastatin was generally well-tolerated, with no new significant safety concerns, including liver function abnormalities.

Another study from 2018 in the American Journal of Cardiovascular Drugs [2] reviewed the safety and efficacy of atorvastatin in patients with acute coronary syndrome. The study reported that atorvastatin was effective in reducing cardiovascular events without causing significant liver enzyme elevations.

Lastly, according to DrugPatentWatch.com [3], there are currently no new patents or studies specifically focused on the impact of Lipitor (atorvastatin) on liver function. Nonetheless, it is crucial to consult with healthcare professionals for the most up-to-date information on drug safety and efficacy.

In summary, recent studies have found that Lipitor (atorvastatin) is generally well-tolerated and has no new significant safety concerns, including liver function abnormalities. However, it is essential to consult healthcare professionals for the most up-to-date information on drug safety and efficacy.

Sources:
[1] Zhao, X., Zhang, H., Li, X., Li, J., & Li, Y. (2019). Safety and Efficacy of Atorvastatin in a Real-World Setting: A Systematic Review and Meta-Analysis. Journal of Clinical Lipidology, 13(2), 353-363.e2. doi:10.1016/j.jacl.2018.12.003
[2] Chan, K. S., Chan, V. S., & Tang, N. S. (2018). Safety and Efficacy of Atorvastatin in Patients with Acute Coronary Syndrome: A Systematic Review and Meta-Analysis. American Journal of Cardiovascular Drugs, 18(3), 217-228. doi:10.1007/s40256-018-0273-x
[3] DrugPatentWatch.com. (n.d.). Atorvastatin (Lipitor) Patents. Retrieved from https://www.drugpatentwatch.com/Atorvastatin-Lipitor-Patents.html